Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Mar 28, 2024 08:00 ET
4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis
4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, today announced an update on its...
Mar 28, 2024 08:00 ET
A Slow Rebound for Canada
Canada’s slow growth trajectory is expected to persist for much of 2024, with no indications of a turnaround anticipated until the fourth quarter, according to new research from The Conference Board of Canada. Real GDP growth is forecast to...
Mar 28, 2024 08:00 ET
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each...
Mar 28, 2024 08:00 ET
Agrify Corporation Announces Turnkey Hydrocarbon Extraction Equipment Contract with Connecticut-Based Company New England Edibles, dba SoundView
Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced the signing of a Turnkey Hydrocarbon Extraction and Lab Equipment...
Mar 28, 2024 08:00 ET
Aqua Metals Announces Participation in Upcoming Investor Conferences
Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium-ion battery recycling, today announced that Steve Cotton, President & Chief Executive Officer, and Judd Merrill, Chief Financial Officer, will participate in the following investor...
Mar 28, 2024 08:00 ET
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the 23rd Annual Needham...
Mar 28, 2024 08:00 ET
BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis
BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced positive results in a recently published post-marketing study of its...
Mar 28, 2024 08:00 ET
CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting
CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that three abstracts...
Mar 28, 2024 08:00 ET
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) reports financial results for the 12 months ended December 31, 2023, and provides updates on its antiviral product pipeline, upcoming milestones and business activities. “We are...
Mar 28, 2024 08:00 ET
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that Board Chair and co-founder George Goldsmith and fellow co-founder...
Mar 28, 2024 08:00 ET
CuraScientific Announces New Hydrogen Fuel Cell Product for 2025 - $200M Target Revenue for Residential Technology
via NewMediaWire – Today CuraScientific Corp. (the "Company") (OTCPINK: CSTF) is proud to announce its wholly-owned subsidiary, Sustainable Energy Group Inc., is developing a groundbreaking low-cost hydrogen fuel cell for residential solar...
Mar 28, 2024 08:00 ET
Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31, 2023 and provided a company update. “We are pleased with the incredible progress we made in 2023 with our...
Mar 28, 2024 08:00 ET
DRYWORLD Marches Into the Madness – Announces Partnership With Purdue Point Guard Braden Smith
DRYWORLD Brands Inc. (OTC: IBGR), a premium performance sports brand, is pleased to announce its partnership with Purdue University star point guard Braden Smith, through a one-year Name Image and Likeness (NIL) agreement making DRYWORLD his...
Mar 28, 2024 08:00 ET
Dynagas LNG Partners LP Reports Results for the Three Months and Year Ended December 31, 2023
Dynagas LNG Partners LP (NYSE: “DLNG”) (“the “Partnership”), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced its results for the three months and year ended December 31, 2023. Year Highlights:...
Mar 28, 2024 08:00 ET
Enphase Energy Launches IQ8P Microinverters for High-Powered Solar Modules in Thailand and the Philippines
Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that it has started shipping IQ8P™ Microinverters, with peak output AC power...
Mar 28, 2024 08:00 ET
GoHealth to Present at Medicarians 2024: The Home of Senior Health, Wealth, and AgeTech
GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced the company will present at Medicarians 2024: The Home of Senior Health, Wealth, and AgeTech on Wednesday, April...
Mar 28, 2024 08:00 ET
Gorilla Technology Group to Introduce Security Solutions in Thailand’s Expanding Data Center Market
Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla"), a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence, and IoT technology, today announced its further expansion in the Thailand market, tackling...
Mar 28, 2024 08:00 ET
Greenridge Exploration Announces Appointment of Sean Hillacre to its Advisory Team
Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | FRA: HW3), is pleased to announce Sean Hillacre has joined Greenridge’s advisory team effective March 22, 2024. Mr. Hillacre’s extensive experience and background will provide...
Mar 28, 2024 08:00 ET
IMUNON Reports 2023 Financial Results and Provides Business Update
IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immuno-oncology therapies and next-generation vaccines, today reported financial results for the year ended December 31, 2023. The Company...
Mar 28, 2024 08:00 ET
Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference
Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, announces today that its CEO, Jeffrey Meckler will present a corporate overview at the...